.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Chubb
Farmers Insurance
Fish and Richardson
Express Scripts
Colorcon
Argus Health
Harvard Business School
Mallinckrodt
Healthtrust

Generated: July 22, 2017

DrugPatentWatch Database Preview

Benazepril hydrochloride; hydrochlorothiazide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for benazepril hydrochloride; hydrochlorothiazide and what is the scope of benazepril hydrochloride; hydrochlorothiazide patent protection?

Benazepril hydrochloride; hydrochlorothiazide
is the generic ingredient in two branded drugs marketed by Mylan Pharms Inc, Sandoz, Us Pharms Holdings I, Actavis Labs Fl Inc, Ivax Sub Teva Pharms, Sun Pharm Inds Ltd, Mylan, and Apotex Inc, and is included in eight NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for benazepril hydrochloride; hydrochlorothiazide. Twelve suppliers are listed for this compound.

Summary for Generic Name: benazepril hydrochloride; hydrochlorothiazide

Tradenames:2
Patents:1
Applicants:8
NDAs:8
Drug Master File Entries: see list14
Suppliers / Packagers: see list12
Clinical Trials: see list2,576
Drug Prices:see low prices
DailyMed Link:benazepril hydrochloride; hydrochlorothiazide at DailyMed

Pharmacology for Ingredient: benazepril hydrochloride; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL076631-004Feb 11, 2004ABRXNoNo► Subscribe► Subscribe
Mylan
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL076688-003Feb 11, 2004ABRXNoNo► Subscribe► Subscribe
Mylan
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL076688-004Feb 11, 2004ABRXNoNo► Subscribe► Subscribe
Mylan
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL076688-002Feb 11, 2004ABRXNoNo► Subscribe► Subscribe
Sun Pharm Inds Ltd
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL077483-002Sep 8, 2005DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: benazepril hydrochloride; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharms Holdings I
LOTENSIN HCT
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL020033-001May 19, 19924,410,520*PED► Subscribe
Us Pharms Holdings I
LOTENSIN HCT
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL020033-004May 19, 19924,410,520*PED► Subscribe
Us Pharms Holdings I
LOTENSIN HCT
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL020033-003May 19, 19924,410,520*PED► Subscribe
Us Pharms Holdings I
LOTENSIN HCT
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL020033-002May 19, 19924,410,520*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
US Army
Covington
Argus Health
Queensland Health
Deloitte
Moodys
McKesson
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot